Maxim D. Oleynikov
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 detection and testing 1
-
- RNA and protein synthesis mechanisms 1
- Gene Regulatory Network Analysis 1
- RNA Research and Splicing 1
- CRISPR and Genetic Engineering 1
- Co-authors
- Jatin Machhi (4 shared papers)Howard Eliot Gendelman (4 shared papers)Wilson R. Blomberg (4 shared papers)Bhavesh D. Kevadiya (4 shared papers)Jonathan Herskovitz (4 shared papers)Mahmudul Hasan (4 shared papers)Linda Dongxia Chang (3 shared papers)Milankumar Patel (3 shared papers)
- Journals
- Journal of Neuroimmune Pharmacology (3 papers)Advanced Drug Delivery Reviews (1 paper)Nature Methods (1 paper)Biomaterials (1 paper)Nature Materials (1 paper)
- Partner nations
- United StatesIndiaChina
In The Last Decade
Maxim D. Oleynikov
7 papers receiving 1.2k citations
Maxim D. Oleynikov's Hit Papers
Peers
Comparison fields: 5 of 115
- Infectious Diseases 688
- General Dentistry 4
- Neurology 62
- Biomedical Engineering 149
- Modeling and Simulation 19
Countries citing papers authored by Maxim D. Oleynikov
This map shows the geographic impact of Maxim D. Oleynikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim D. Oleynikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim D. Oleynikov more than expected).
Fields of papers citing papers by Maxim D. Oleynikov
This network shows the impact of papers produced by Maxim D. Oleynikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim D. Oleynikov. The network helps show where Maxim D. Oleynikov may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxim D. Oleynikov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Diagnostics for SARS-CoV-2 infections Hit paper breakdown → | 2021 | 650 |
| 2 | 2020 | 434 | |
| 3 | 2021 | 84 | |
| 4 | 2021 | 45 | |
| 5 | 2019 | 24 | |
| 6 | 2021 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2025 | 0 |
About Maxim D. Oleynikov
Maxim D. Oleynikov is a scholar working on Infectious Diseases, Molecular Biology, Materials Chemistry, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (2 papers), SARS-CoV-2 detection and testing (1 paper), RNA and protein synthesis mechanisms (1 paper), Gene Regulatory Network Analysis (1 paper), RNA Research and Splicing (1 paper), CRISPR and Genetic Engineering (1 paper) and Luminescence and Fluorescent Materials (1 paper). The work is most often cited by research in Infectious Diseases (688 citations), General Dentistry (4 citations), Neurology (62 citations), Biomedical Engineering (149 citations) and Modeling and Simulation (19 citations). Maxim D. Oleynikov has collaborated with scholars based in United States, India and China. Frequent co-authors include Jatin Machhi, Howard Eliot Gendelman, Wilson R. Blomberg, Bhavesh D. Kevadiya, Jonathan Herskovitz, Mahmudul Hasan, Linda Dongxia Chang, Milankumar Patel, Ahmed M. Senan and Santhi Gorantla. Their work appears in journals such as Journal of Neuroimmune Pharmacology, Advanced Drug Delivery Reviews, Nature Methods, Biomaterials and Nature Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.